Who owns PHARMACYTE BIOTECH INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Pharmacyte Biotech with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Pharmacyte Biotech stock

Who bought or sold PHARMACYTE BIOTECH INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
K2 Principal Fund 305k $655k 18% Dec 2023
 View chart
Geode Capital Management 200k $475k -9% Mar 2024
 View chart
Vanguard Group 175k $414k 2% Mar 2024
 View chart
Equitec Proprietary Markets 83k $196k 0% Mar 2024
 View chart
Susquehanna International 41k $98k 100% Mar 2024
 View chart
Dimensional Fund Advisors 25k $58k -16% Mar 2024
 View chart
Schonfeld Strategic Advisors 24k $56k 1% Mar 2024
 View chart
BlackRock 21k $50k -49% Mar 2024
 View chart
Northern Trust 19k $46k 0% Mar 2024
 View chart
Citadel Advisors 14k $34k -66% Mar 2024
 View chart
Acadian Asset Management 3.6k $8.0k -50% Mar 2024
 View chart
Tower Research Capital 3.2k $7.7k 165% Mar 2024
 View chart
Advisor Group Holdings 1.8k $4.2k 1% Mar 2024
 View chart
CWM 954.00 $2.0k 0% Mar 2024
 View chart
Aspire Private Capital 800.00 $1.9k 0% Mar 2024
 View chart
Covestor 226.00 $1.0k 0% Mar 2024
 View chart
Royal Bank of Canada 156.00 $0 -41% Mar 2024
 View chart
Wells Fargo & Company 55.00 $129.998000 0% Mar 2024
 View chart
Bank of America Corporation 54.00 $128.001600 -13% Mar 2024
 View chart
Private Wealth Management Group 42.00 $100.002000 0% Mar 2024
 View chart
Jpmorgan Chase & Co 18.00 $43.000200 50% Mar 2024
 View chart
Highlander Capital Management 14.00 $32.999400 0% Mar 2024
 View chart
Sachetta 14.00 $31.000200 0% Mar 2024
 View chart
UBS Group 9.00 $21.600000 -31% Mar 2024
 View chart
BFSG 7.00 $17.000200 100% Mar 2024
 View chart
Goss Wealth Management 3.00 $6.999900 0% Mar 2024
 View chart
Morgan Stanley 3.00 $7.500000 0% Mar 2024
 View chart

Who sold out of Pharmacyte Biotech?

Fund or Company Name Date Sold Shares Held Valued At
Bank of New York Mellon Dec 2023 17k $36k
Squarepoint Ops Dec 2023 15k $32k